Skip Navigation



BJA Advance Access published online on April 1, 2005

British Journal of Anaesthesia, doi:10.1093/bja/aei127
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/6/727    most recent
aei127v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baumert, J.-H.
Right arrow Articles by Rossaint, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumert, J.-H.
Right arrow Articles by Rossaint, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2005. All rights reserved. For Permissions, please e-mail: journal.permissions@oupjournals.org
Accepted February 2, 2005

Laboratory Investigation

Haemodynamic effects of haemorrhage during xenon anaesthesia in pigs

J.-H. Baumert 1*, K. E. Hecker 1, M. Hein 1, S. M. Reyle-Hahn 2, N. A. Horn 1, and R. Rossaint 1

1 Klinik fuer Anaesthesiologie, Universitaetsklinikum Aaachen, Pauwelsstrasse 30, D-52074 Aachen, Germany
2 Department of Anaesthesia, Waldkrankenhaus Spandau, Berlin, Germany

* To whom correspondence should be addressed.
J.-H. Baumert, E-mail: jbaumert{at}ukaachen.de


   Abstract

Background. It was hypothesized that xenon would stabilize mean arterial pressure (MAP) in haemorrhagic shock, recovery, and volume resuscitation, because a higher MAP has been observed with xenon, when compared with isoflurane anaesthesia. The responses to haemorrhage and subsequent volume replacement were therefore compared between xenon and isoflurane anaesthesia, in pigs.

Methods. Pigs were randomized to anaesthesia with xenon 0.55 MAC (group Xe, n=9) or isoflurane 0.55 MAC (group Iso, n=9), each with remifentanil 0.5 µg kg-1 min-1. MAP, heart rate, cardiac output (CO), and left ventricular fractional area change (FAC) were collected at control (1), after haemorrhage (20 ml kg-1) (2), after 10 min of recovery (3), after volume replacement (4), and 30 min later (5). Data were analysed by two-way repeated measures ANOVA.

Results. Blood loss decreased MAP (Xe: 103 [21] to 53 [24] mm Hg; Iso: 92 [18] to 55 [14] mm Hg) and CO (Xe: 4.1 [0.8] to 2.6 [0.5] litre min-1; Iso: 5.1 [1.1] to 3.8 [1.2] litre min-1), in spite of significant tachycardia. MAP and CO recovered to about 75% of control, and subsequent volume replacement completely reversed symptoms in both groups, but increased FAC only with xenon.

Conclusion. Haemodynamic response to acute haemorrhage appeared faster with xenon/remifentanil than with isoflurane/remifentanil anaesthesia. In particular MAP decrease and short-term recovery were more marked with xenon (P<0.02). In the xenon group, volume replacement increased FAC compared with control and isoflurane (P<0.02).

Keywords: measurement techniques, trans-oesophageal echocardiography; model; model, pigs; xenon.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J.-H. Baumert, M. Hein, K. E. Hecker, S. Satlow, J. Schnoor, and R. Rossaint
Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk
Br. J. Anaesth., June 1, 2007; 98(6): 722 - 727.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.